Carl Zeiss Meditec Dividends and Buybacks
Dividend criteria checks 3/6
Carl Zeiss Meditec is a dividend paying company with a current yield of 1.06% that is well covered by earnings.
Key information
1.1%
Dividend yield
3.0%
Buyback Yield
| Total Shareholder Yield | 4.1% |
| Future Dividend Yield | 1.6% |
| Dividend Growth | 10.1% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | €0.600 |
| Payout ratio | 34% |
Recent dividend and buyback updates
Recent updates
Carl Zeiss Meditec (ETR:AFX) Will Pay A Smaller Dividend Than Last Year
Mar 23
Shareholders Will Probably Be Cautious Of Increasing Carl Zeiss Meditec AG's (ETR:AFX) CEO Compensation At The Moment
Mar 20After Leaping 25% Carl Zeiss Meditec AG (ETR:AFX) Shares Are Not Flying Under The Radar
Mar 15These 4 Measures Indicate That Carl Zeiss Meditec (ETR:AFX) Is Using Debt Extensively
Mar 03Carl Zeiss Meditec (ETR:AFX) Might Be Having Difficulty Using Its Capital Effectively
Feb 10More Unpleasant Surprises Could Be In Store For Carl Zeiss Meditec AG's (ETR:AFX) Shares After Tumbling 26%
Jan 10Is Carl Zeiss Meditec AG (ETR:AFX) Potentially Undervalued?
Dec 28
AI-Powered Innovations Like KINEVO 900 S And VISUMAX 800 Set To Drive Revenue Growth
Dec 22 New product pipeline and integration of DORC expected to drive revenue and enhance net margins with innovative AI medical solutions.Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)
Dec 04Carl Zeiss Meditec AG's (ETR:AFX) Share Price Could Signal Some Risk
Nov 19Some Investors May Be Worried About Carl Zeiss Meditec's (ETR:AFX) Returns On Capital
Sep 19Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?
Sep 06Are Investors Undervaluing Carl Zeiss Meditec AG (ETR:AFX) By 27%?
Aug 23At €62.50, Is It Time To Put Carl Zeiss Meditec AG (ETR:AFX) On Your Watch List?
Aug 09Carl Zeiss Meditec AG's (ETR:AFX) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio
Jul 11Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Stalled
Jun 10Carl Zeiss Meditec AG's (ETR:AFX) Popularity With Investors Is Under Threat From Overpricing
May 26Carl Zeiss Meditec AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
May 11Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)
May 09Stability and Growth of Payments
Fetching dividends data
Stable Dividend: AFX's dividend payments have been volatile in the past 10 years.
Growing Dividend: AFX's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Carl Zeiss Meditec Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (AFX) | 1.1% |
| Market Bottom 25% (DE) | 1.5% |
| Market Top 25% (DE) | 4.4% |
| Industry Average (Medical Equipment) | 2.0% |
| Analyst forecast (AFX) (up to 3 years) | 1.6% |
Notable Dividend: AFX's dividend (1.06%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1.48%).
High Dividend: AFX's dividend (1.06%) is low compared to the top 25% of dividend payers in the German market (4.57%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (33.8%), AFX's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (55.2%), AFX's dividend payments are covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/17 23:56 |
| End of Day Share Price | 2025/04/17 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Carl Zeiss Meditec AG is covered by 32 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Samuel England | Berenberg |
| Scott Bardo | Berenberg |
| Julien Ouaddour | BofA Global Research |